We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
-5.16%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$10.8B
AUM Growth
-$966M
Cap. Flow
-$176M
Cap. Flow %
-1.63%
Top 10 Hldgs %
11.09%
Holding
1,042
New
69
Increased
438
Reduced
347
Closed
31

Sector Composition

Rank Sector Weight
1 Industrials 17.37%
2 Healthcare 16.24%
3 Technology 16.09%
4 Financials 15.05%
5 Consumer Discretionary 12.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
426
Elevance Health
ELV
$86.6B
$81K ﹤0.01%
187
+20
+12% +$8.03K
NEM icon
427
Newmont
NEM
$124B
$81K ﹤0.01%
1,674
+1
+0.1% +$44
AXP icon
428
American Express
AXP
$232B
$79K ﹤0.01%
294
-1
-0.3% -$296
CTAS icon
429
Cintas
CTAS
$81.4B
$79K ﹤0.01%
382
+20
+6% +$3.98K
BKNG icon
430
Booking.com
BKNG
$159B
$78K ﹤0.01%
425
+25
+6% +$4.78K
SO icon
431
Southern Company
SO
$106B
$78K ﹤0.01%
847
+350
+70% +$30.3K
HLT icon
432
Hilton Worldwide
HLT
$72.6B
$76K ﹤0.01%
336
+177
+111% +$44.1K
FISV
433
Fiserv Inc
FISV
$27.4B
$74K ﹤0.01%
335
+21
+7% +$4.6K
VUG icon
434
Vanguard Morningstar Growth ETF
VUG
$229B
$74K ﹤0.01%
1,200
AMAT icon
435
Applied Materials
AMAT
$435B
$72K ﹤0.01%
496
+12
+2% +$2.02K
GIS icon
436
General Mills
GIS
$20.4B
$72K ﹤0.01%
1,207
+60
+5% +$3.6K
BMY icon
437
Bristol-Myers Squibb
BMY
$130B
$71K ﹤0.01%
1,168
-10
-0.8% -$583
NOC icon
438
Northrop Grumman
NOC
$82B
$71K ﹤0.01%
139
+15
+12% +$7.16K
TJX icon
439
TJX Companies
TJX
$169B
$71K ﹤0.01%
585
-88
-13% -$10.7K
VRTX icon
440
Vertex Pharmaceuticals
VRTX
$133B
$69K ﹤0.01%
143
+11
+8% +$5.13K
PANW icon
441
Palo Alto Networks
PANW
$315B
$68K ﹤0.01%
401
+50
+14% +$9.25K
WEC icon
442
WEC Energy
WEC
$35.6B
$68K ﹤0.01%
625
+5
+0.8% +$511
ICFI icon
443
ICF International
ICFI
$1.61B
$67K ﹤0.01%
784
-219,107
-100% -$22.9M
PLD icon
444
Prologis
PLD
$134B
$67K ﹤0.01%
596
+117
+24% +$13.5K
SYF icon
445
Synchrony
SYF
$25.8B
$67K ﹤0.01%
1,258
+47
+4% +$2.91K
FCX icon
446
Freeport-McMoran
FCX
$96.9B
$66K ﹤0.01%
1,750
+98
+6% +$3.75K
PEG icon
447
Public Service Enterprise Group
PEG
$37.8B
$66K ﹤0.01%
796
+34
+4% +$2.84K
NVS icon
448
Novartis
NVS
$290B
$65K ﹤0.01%
584
+317
+119% +$33.7K
PODD icon
449
Insulet
PODD
$10.1B
$65K ﹤0.01%
249
+133
+115% +$36K
GEV icon
450
GE Vernova
GEV
$277B
$65K ﹤0.01%
213
+37
+21% +$12.9K

Similar funds

GW&K Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, GW&K Investment Management held 1,042 positions worth $10.8B, down 8.2% from $11.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q1 2025 filing shows 69 new, 438 increased, 347 reduced and 31 closed positions. Its largest new stake was Powell Industries: 492,876 shares worth $28M. The largest sale was Intra-Cellular Therapies Inc., an estimated $155M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Technology.

  • GW&K Investment Management's largest Q1 2025 buy was Powell Industries: 492,876 shares worth $28M.
  • GW&K Investment Management added most to Citizens Financial Group in Q1 2025, an estimated $32.4M increase.
  • GW&K Investment Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $155M.
  • GW&K Investment Management fully exited TriNet in Q1 2025, selling an estimated $12.7M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $10.8B portfolio in Q1 2025.
  • GW&K Investment Management opened 69 new positions and closed 31 in Q1 2025.
  • GW&K Investment Management's portfolio value fell 8.2% quarter-over-quarter to $10.8B.

Based on GW&K Investment Management's 13F filing for Q1 2025, filed 5 May 2025.